side effect difference between semaglutide and tirzepatide vs. Tirzepatide: Which Is the Best at Managing Weight Loss? Tirzepatide vs. Semaglutide for Weight

Scenario 2 (delayed or limited approval): If cardiovascular safety concerns emerge (glucagon agonism theoretically increases heart rate and may elevate blood pressure in susceptible individuals) or gastrointestinal tolerability limits real-world adherence, retatrutide remains investigational

What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1

West JAX

An NDA filing is expected in late 2026 or early 2027, with FDA approval potentially in late 2027 or the first half of 2028

Switch to morning